Erythromycin Tablet, Film Coated
Product Images NDC 52536-103

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Erythromycin (NDC 52536-103). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Wilshire Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Erythromycin 01)

Chemical structure diagram of the active ingredient erythromycin, showing its detailed molecular arrangement including rings, methyl groups, hydroxyl groups, and other chemical bonds, as depicted in the image.*

FDA Label Image

Principal Display Panel (250 mg Tablet Bottle Label)

Label for Erythromycin Tablets USP, film-coated, 250 mg strength. The package contains 30 tablets and is distributed by Wilshire Pharmaceuticals, Inc. The label includes storage instructions, tablet identification, dosage form, and a barcode. It specifies oral route and a caution not to accept if seal over bottle opening is broken or missing.*

FDA Label Image

Principal Display Panel (500 mg Tablet Bottle Label)

Label for Erythromycin 500 mg film-coated tablets from Wilshire Pharmaceuticals. The package contains 30 tablets. The label includes storage instructions, dosage identification, and a barcode. The product is an oral prescription drug.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.